Fidelis Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Sell |
4,074
-197
| -5% | -$88.4K | 0.17% | 108 |
|
|
2025
Q1 | $1.81M | Buy |
4,271
+628
| +17% | +$266K | 0.19% | 95 |
|
|
2024
Q4 | $2.16M | Buy |
3,643
+472
| +15% | +$280K | 0.22% | 85 |
|
|
2024
Q3 | $1.83M | Buy |
3,171
+25
| +0.8% | +$14.4K | 0.22% | 85 |
|
|
2024
Q2 | $1.85M | Sell |
3,146
-195
| -6% | -$115K | 0.26% | 73 |
|
|
2024
Q1 | $1.94M | Buy |
3,341
+202
| +6% | +$117K | 0.29% | 68 |
|
|
2023
Q4 | $1.67M | Buy |
3,139
+256
| +9% | +$136K | 0.37% | 58 |
|
|
2023
Q3 | $1.46M | Buy |
2,883
+257
| +10% | +$130K | 0.5% | 43 |
|
|
2023
Q2 | $1.37M | Buy |
2,626
+133
| +5% | +$69.4K | 0.5% | 50 |
|
|
2023
Q1 | $1.36M | Buy |
2,493
+1,158
| +87% | +$633K | 0.58% | 45 |
|
|
2022
Q4 | $729K | Buy |
+1,335
| New | +$729K | 0.86% | 32 |
|